Could SARS-CoV-2 be associated with emphysematous gastritis?

Emphysematous gastritis on the post COVID-19 spectrum: A case report

“…[2] A higher incidence of the condition or rigorous diagnostic procedures brought on by enhanced vigilance may be to blame for the rise in reports of the ailment. Additionally, just one instance of emphysematous gastritis in a patient who tested positive for COVID-19 has been documented by Garrosa et al [3] Only two cases of emphysematous gastritis caused by a COVID-19 infection have been documented in the literature, and our case report documents one of them. This opens the door for additional investigation into the possibility that a SARS CoV2 infection can serve as a risk factor independently.…”

“…Emphysematous gastritis, as opposed to gastric emphysema, is brought on by a bacterial infection that can develop locally through the mucosa or spread throughout the body from a distant location. Patients usually present with severe abdominal pain, nausea, vomiting (occasionally hematemesis), and fever [2,3] . Physical examination findings include abdominal distension and decreased bowel sounds.…”

“…Although COVID-19's problems have emerged as a crucial area of current study, they are still mostly unknown. Sonsoles Garrosa-Muoz et al study's is the only one to demonstrate a connection between the SARS CoV-2 and emphysematous gastritis [3] . We report a case of emphysematous gastritis in a COVID-recovered patient with no other known risk factors.…”

“…Microorganisms associated with emphysematous gastritis include Streptococcus species, Escherichia coli, Enterobacter species, etc. Only 59 cases have been reported in literature based on a review by Watson et al, and no guidelines are available for the management of emphysematous gastritis [3] . However, early diagnosis and initiation of medical management have been noted to improve outcomes.…”

Emphysematous Gastritis in a Patient With Recent COVID-19 Infection

“…There have been only two other documented cases of emphysematous gastritis in patients with COVID-19 infection, apart from one other case in a patient who had recently recovered from COVID-19 infection [ 3 , 11 , 12 ]. Although the association between emphysematous gastritis and COVID-19 infection remains unclear, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can take advantage of the gastrointestinal angiotensin-converting enzyme 2 receptors, inducing wall inflammation, barrier compromise, and dysbiosis [ 13 ].…”